Clinical Trials Browser

Phase 2 × Drug-Related Side Effects and Adverse Reactions × Drug Therapy × Clear all

NCT04635956 2020-11-19

Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas

Phase 2 Unknown

Uterine Cervical Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT02549911 2015-09-15

HIPEC, Intravenous Chemotherapy and Surgery for the Treatment of Advanced GC With Peritoneal Metastasis

Phase 2 Unknown

Gastrointestinal

Stomach Neoplasms, Drug-Related Side Effects and Adverse Reactions